Biomedical Engineering Reference
In-Depth Information
35. J. Cheng, B.A. Teply, I. Sherifi , J. Sung, G. Luther, F.X. Gu, E. Levy-Nissenbaum, A.F. Radovic-
Moreno, R. Langer, and O.C. Farokhzad, Formation of functionalized PLGA-PEG nanoparticles for
in vivo
targeted drug delivery,
Biomaterials
28 (2007) 869-876.
36. M.L. Hans and A.M. Lowman, Biodegradable nanoparticles for drug delivery and targeting,
Current
Opinion in Solid State and Materials Science
6 (2002) 319-327.
37. M. Rawat, D. Singh, S. Saraf, and S. Saraf, Nanocarriers: Promising vehicles for bioactive drugs,
Biological and Pharmaceutical Bulletin
29 (2006) 1790-1798.
38. V.P. Torchilin, Targeted polymeric micelles for delivery of poorly soluble drugs,
Cellular and Molecu-
lar Life Sciences
61 (2004) 2549-2559.
39. T.C. Yih and M. Al-Fandi, Engineered nanoparticles as precise drug delivery systems,
Journal of
Cellular Biochemistry
97 (2006) 1184-1190.
40. S.Y. Kim, S.H. Cho, L.Y. Chu, and Y.M. Lee, Biotin-conjugated block copolymeric nanoparticles for
tumor-targeted drug delivery systems, Macromolecular Research, in press.
41. C.P. Reis, R.J. Neufeld, A.J. Ribeiro, F. Veiga, Nanoencapsulation II. Biomedical applications and cur-
rent status of peptide and protein nanoparticulate delivery systems,
Nanomedicine: Nanotechnology,
Biology, and Medicine
2 (2006) 53-65.
42. E. Forssen and M. Willis, Ligand-targeted liposomes,
Advanced Drug Delivery Reviews
29 (1998)
249-271.
43. B.J. Lestini, S.M. Sagnella, Z. Xu, M.S. Shive, N.J. Richter, J. Jayaseharan, A.J. Case, K. Kottke-
Marchant, J.M. Anderson, R.E. Marchant, Surface modifi cation of liposomes for selective cell targeting
in cardiovascular drug delivery,
Journal of Controlled Release
78 (2002) 235-247.
44. T. Terada, M. Iwai, S. Kawakami, F. Yamashita, and M. Hashida, Novel PEG-matrix metallopreotein-
ase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective
targeting,
Journal of Controlled Release
111 (20 0 6) 333 -342.
45. R.I. Pakunlu, Y. Wang, W. Tsao, V. Pozharov, T.J. Cook, and T. Minko, Enhancement of the effi cacy of
chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic
cellular defense: Novel multicomponent delivery system,
Cancer Research
64 (2004) 6214-6224.
46. M. Singh, Transferrin as a targeting ligand for liposomes and anticancer drugs,
Current Pharmaceuti-
cal Design
5 (1999) 443-451.
47. J. Huwyler, J. Yang, and W.M. Pardridge, Receptors mediated delivery of daunomycin using
immunoliposomes: Pharmacokinetics and tissue distribution in the rat,
The Journal of Pharmacology
and Experimental Therapeutics
282 (1997) 1541-1546.
48. R.L. Juliano,
Targeted Drug Deliver y
, Springer-Verlag, Berlin Heidelberg, Germany, 1991.
49. P.D. Scholes, A.G.A. Coombes, M.C. Davies, L. Illum, and S.S. Davis, Particle engineering of biode-
gradable colloids for site-specifi c drug delivery, in
Controlled Drug Delivery
, K. Park (Ed.), American
Chemical Society, Danvers, MA, 1997, pp. 73-106.
50. F. Puisieux, G. Barratt, G. Couarraze, P. Couvreur, J.P. Devissaguet, C. Dubernet, E. Fattal,
H. Fessi, C. Vauthier, and S. Benita, Polymeric micro- and nanoparticles as drug carriers, in
Polymeric
Biomaterials
, S. Dumitriu (Ed.), Marcel Dekker, Inc., New York, 1994, pp. 749-794.
51. D. Maysinger, O. Berezovska, R. Savic, P.L. Soo, and A. Eisenberg, Block copolymers modify the inter-
nalization of micelle-incorporated probes into neutral cells,
Biochimica et Biophysica Acta
1539 (2001)
205-217.
52. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov, Pluronic block copolymers for overcoming drug resis-
tance in cancer,
Advanced Drug Delivery Reviews
54 (2002) 759-779.
53. E.R. Gillies and J.M.J. Frechet, Dendrimers and dendritic polymers in drug delivery,
Drug Discovery
Today
10 (2005) 35-43.
54. A.K. Patri, J.F. Kukowska-Latallo, and J.R. Barker, Targeted drug delivery with dendrimers: Com-
parison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex,
Advanced Drug Delivery Reviews
57 (2005) 2203-2214.
55. U. Gupta, H.B. Agashe, A. Asthana, and N.K. Jain, A review of
in vitro-in vivo
investigations on den-
drimers: The novel nanoscopic drug carriers,
Nanomedicine: Nanotechnology, Biology, and Medicine
2 (2006) 66-73.
56. G.A. Hughes, Nanostructure-mediated drug delivery,
Nanomedicine: Nanotechnology, Biology, and
Medicine
1 (2005) 22-30.
57. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N.B. Mckeown, and A. D'Emanuele, The infl uence
of surface modifi cation on the cytotoxicity of PAMAM dendrimers,
International Journal of Pharma-
ceutics
252 (2003) 263-266.
